Protalix Biotherapeutics Inc (PLX)
Operating Cash Flow Growth
-98.74%
Quarterly · Period ending:
PLX Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-98.74%period ending
Latest reported-98.74%period ending
PLX Quarterly Cash from Operations YoY % (-257.14% → -98.74%)
Year-over-year change
High-resolution chart · PNG
PLX operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 1,230.857% | |
| -2.9794% | |
| 250.8302% | |
| 87.936% | |
| 85.9555% | |
| 83.7259% | |
| 76.3382% | |
| 54.1465% | |
| -200.6346% | |
| -539.1% | |
| -123.5294% | |
| -244% | |
| 472.7273% | |
| 0% | |
| -1,600% | |
| -257.1429% |